| Characteristics | Categories | n (%) |
| Opportunistic Infections |
|
|
|
| Herpes zoster | 27 (25.5) |
|
| Tuberculosis | 11 (10.4) |
|
| Cerebral toxoplasmosis | 2 (1.9) |
|
| Oral candidiasis | 20 (18.9) |
| Risk factors for HIV |
|
|
|
| Previous STIs | 16 (15.1) |
|
| Scarification | 45 (42.5) |
|
| Surgical procedure | 15 (14.2) |
|
| Blood transfusion | 8 (7.5) |
| Symptoms of HIV |
|
|
|
| Weight loss | 42 (39.6) |
|
| Fever in the last 1 month | 47 (44.3) |
|
| Diarrhoea in last 1 month | 2 (1.9) |
|
| Priorigo/Skin rash | 16 (15.1) |
| WHO HIV staging |
|
|
|
| Stage 1 | 27 (25.5) |
|
| Stage 2 | 23 (21.7) |
|
| Stage 3 | 48 (45.3) |
|
| Stage 4 | 8 (7.5) |
| ART regimen |
|
|
|
| NVP-based | 23 (21.7) |
|
| TDF-3TC-NVP | 8 (7.5) |
|
| AZT-3TC-NVP | 15 (14.2) |
|
| EFV-based | 80 (75.5) |
|
| TDF-3TC-EFV | 77 (72.6) |
|
| AZT-3TC-EFV | 3 (2.8) |
|
| 2nd Line (ATV/r-TDF) | 3 (2.8) |
| Change of ART regimen |
|
|
|
| No | 67 (63.2) |
|
| Yes | 39 (36.7) |
| Reason for change of regimen |
|
|
|
| Drug stock out | 35 (33.0) |
|
| Suspected failure | 3 (2.8) |
|
| Allergic reaction | 1 (0.9) |